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No method of testing a given substance for its possible carcinogenic effect,
nor of comparing the carcinogenicity of two or more substances, is at present
universally accepted as a routine procedure.
Attempted comparisons of published data are not satisfactory, due to the
variability of the methods of application which have been employed and the
different types of animals used.
The ability to produce recognisably malignant tumours is generally accepted
as proof of carcinogenicity, but this may often be a lengthy procedure. There is
room therefore for a reliable short term test, using this criterion, by which direct
comparions of various substances could be made. Such a test would increase in
value if the effect on several types of tissue could be assessed simultaneouslv,
using only small quantities of the test substance.
Undertaking the investigation of this problem at once raised the question of
which substances to employ in the evaluation of a method which could then be
applied to new or untested material. In this respect I was fortunate, as my col-
leagues Dr. Fell and Dr. Spence were carrying out studies on two series of closely
related polycyclic aromatic hydrocarbons (Fell and Spence, 1962). They made
these available, for biological testing, in a chemically pure solid state, arbitrarily
numbered 1 to 13. The series were derived respectively from pyrene (Table I)
and anthracene (Table II) and include known carcinogens, substances never yet
shown to be carcinogens, and one untested substance.
TABLE L.-Substances of the Pyrene Series Under Test
Reported Tumours in
Code as embryo
number Hydrocarbon carcinogen implants
1. . Pyrene No . No
2. 1,2-Benzopyrene . No No702
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TABLE I-Substances of the Pyrene Series Under Test.
Reported
as
Hydrocarbon carcinogen
3. . 3,4-Benzopyrene
4. . 1,2: 3,4-Dibenzopyrene
5. . 1,2: 4,5-Dibenzopyrene
6. . 1,2: 6,7-Dibenzopyrene
7. . 3,4: 8,9-Dibenzopyrene
8. . 3,4: 9,10-Dibenzopyrene
Yes
Yes
Yes
Not
tested
Yes
Yes
Tumours in
embryo
implants
Yes
Yes
Yes
No
Yes
YesA TEST FOR CARCINOGENICITY
TABLE II.-Substances of the Anthracene Series Under Test
Code
number
Reported
as
carcinogen Hydrocarbon
9. . Anthracene
10. 1,2-Benzanthracene
11. . 1.2 : 3,4-Dibenzanthracene
12. 1,2: 5,6:Dibenzanthracene
No
Yes
No
Yes
Tumours in
embryo
implants
No
No
* No
* Yes
13. 1,2: 7,8-Dibenzanthracene K>
Blind testing was carried out by a number of procedures and the results
obtained by the technique found to be most satisfactory are discussed below.
Rous and Smith (1945) found that, using "C " strainmice, embryo tissuemince
(skin) inoculated into the thigh muscle of adults of the same strain survived and
differentiated. When methylcholanthrene was included in the inoculum, squamous
carcinomas developed in the implanted embryo tissue.
The method from which the following results were obtained was based on their
observations and is described in detail elsewhere (Peacock and Dick, 1963). Using
BALB/c strain mice, individual embryo tissues were implanted surgically into the
thigh muscle of adults of the same strain, where they survived and differentiated,
exciting no reaction on the part of the host tissues (Fig. 1 to 4). When small
quantities of the solid hydrocarbons were included in close apposition to separate
embryo grafts some induced malignant tumours in the implants (Fig. 5 to 12).
These tumours were usually squamous carcinomas, the incidence and types of
embryo tissue affected varying for each hydrocarbon. Multiple tumours differing
histologically sometimes occurred in the same graft and occasional sarcomas were
also seen. The quantity of material required to induce tumours was very small.
By weighing it is estimated never to have been more than 150 ,ug., which is much
less than is required for most other accepted test methods.
Yes Yes
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As a criterion of carcinogenicity the ability to produce histologically recognis-
able malignant lesions in the embryo implants has been used, to accord with the
definition made earlier in this paper.
The choice of embryo tissues against which the hydrocarbons were tested was
made by taking only those which had an epithelial lining in which experimental
tumours have in the past been induced in adult mice. Those originally chosen
were skin, lung, stomach, urinary bladder. Others have since been used but these
four have been the most consistently satisfactory.
EXPLANATION OF PLATES
FIG. 1.-Control stomach implant showing well differentiated squamous and glandular linings.
The manner in which desquamated keratin accumulates is well seen. H. and E. x 92.
FIG. 2.-Control lung implant. Small bronchi are present surrounded by lung tissue. Note
that there is no cellular reaction at the junction between embryo and host tissues. H. and E.
x92.
FIG. 3.-Control skin implant. The cyst contains well formed hair and desquamated keratin.
This is evidence of differentiation as at the time of implantation foetal skin has only rudi-
mentary hair follicles. H. and E. x 92.
FIG. 4.-Control bladder implant. The whole circumference of the bladder is seen. Cyst
formation is not as large as with the stomach implants since there is no accumulation of
keratin. H. and E. x92.
FIG. 5. Stomach embrvo implant with normal glandular lining alongside a squamous carci-
noma. The superficially adenomatous appearance is due to the cutting in cross section of
the supporting stroma of the tumour. Treated with 1,2: 3,4-dibenzopyrene. H. and E.
x92.
FIG. 6.-Stomach embryo implant showing a poorlv differentiated squamous carcinoma.
Treated with 1,2: 3,4-dibenzopyrene. H. and E. x 92.
FIG. 7. Lung embryo implant with squamous carcinoma invading host tissues. A part of a
bronchus is seen at the edge ofthe field. Treated with 3,4: 9,10-dibenzopyrene. H. and E.
x75.
FIG. 8.-Lung embryo implant with an invasive squamous carcinoma. Treated with 3,4: 9,10-
dibenzopyrene. H. and E. x 75.
FIG. 9.-Embryo skin implant. An early carcinoma arising in the squamous epithelial lining
of a cyst. Treated with 3,4-benzopyrene. H. and E. x 75.
FIG. 10.-Embryo skin implant with well-differentiated invasive squamous carcinoma.
Treated with 3,4: 9,10-dibenzopyrene. H. and E. x 75.
FIG. 11. Embryo bladder implant showing an early carcinoma arising in the lining epithelium
of the cyst but not yet invading host tissues. Treated with 3,4: 9,10-dibenzopyrene. H.
and E. x 75.
FIG. 12.-Embryo bladder with a well-differentiated carcinoma. Treated with 3,4: 9,10-
dibenzopyrene. H. and E. x 75.
FIG. 13.-Post mortem appearance of the hind legs of a mouse with skin removed, photo-
graphed under ultra-violet light to show fluorescence at implant sites. The larger tumour
mass has been cut across to show fluorescence deep in the neoplasm. The smaller tumour
shows fluorescence through the intact muscle of the leg. Treated with 3,4: 9,10-dibenzo-
pyrene.
FIG. 14.-Lung embryo implant. This is a small implant most ofwhich is occupied by a single
adenoma. The small focus of lymphoid tissue is of the type sometimes seen in embryo im-
plants. Treated with 1,2: 3,4-dibenzanthracene. H. and E. x 80.
FIG. 15.-Lung embryo implant showing part of two adenomata and normal lung tissue.
Treated with 3,4: 8,9-dibenzopyrene. H. and E. x 80.
FIG. 16.-Embryo stomach implant showing alteration of the stroma in the squamous portion
of the stomach. The precise nature ofthis change has not yet been categorized. There was
an associated malignant lesion in this implant. Treated with 1,2: 5,6-dibenzanthracene.
H. and E. x 80.
FIG. 17.-Embryo bladder implant showing similar changes to those seen in some of the
stomach implants. This was associated with a carcinoma (see Fig. 12). Treated with
3,4: 9,10-dibenzopyrene. All the other implants in which this appearance was noted were of
stomach. H. and E. x80.
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Several implants of each type of tissue were exposed for the arbitrary period
of 16 weeks to each ofthe test hydrocarbons, with the production ofmany malig-
nant tumours. Random samples of these have been passaged through several
generations of new adult hosts.
The analysis of this blind testing of the hydrocarbons showed that the results
tallied closely with what was already known of their behaviour. That is to say,
that only those previously reported as carcinogens (by whatever method had been
employed) produced tumours (Table III). By inspection ofthe implant site under
ultra violet light, the persistence offluorescence was often noted at death (Fig. 13).
This was shown in some sample cases to be due to the respective hydrocarbons or
metabolites. This was found to be independent of any carcinogenic effect. The
presence of a palpable mass was also found to bear no relation to the presence of
a tumour, often being due to the production of cysts filled with keratin.
TABLE III.-Incidence of Tumours in a Seriem ofEmbryo Implant8
Exposed to Hydrocarbons
Hydrocarbon Stomach Lung Skin Bladder
Pyrene . . . 0/3 . lA/I . 0/3 . 0/1
1,2-Benzopyrene . . 0/4 . 0/3 . 0/2 . 0/2
3,4-Benzopyrene . . 1/3 . 2/2 . 2/2 0/1
1,2: 3,4-Dibenzopyrenc . 1/3 . 2/3 2/2 . 1/3
1,2: 4,5-Dibenzopyrene . . 0/1 . 1/2 1/5 . 0/4
1,2: 6,7-Dibenzopyrene . . 0/3 . 0/3 0/3 0/3
3,4: 8,9-Dibenzopyrene . . 0/1 . 1/1 . 1/1 . 0/1
3,4: 9,10-Dibenzopyreio . 6/6 . 6/6 . 4/4 . 2/2
Anthracene . . . . 0/2 . 0/3 . 0/4 . 0/1
1,2-Benzanthracene . * 0/2 . 3A/3 . 0/3 0/3
1,2: 3,4-Dibenzanthracenc . 0/2 . 3A/3 . 0/2 0/3
1,2: 5,6-Dibenzanthracene . 2/2 . 2/3 0/3 . 2/3
1,2: 7,8-Dibenzanthracene . 0/3 . 2/2 . 0/1
Ratio = Tumour induction A = Adenoma without carcinoma. Embryo implants
From Table III it is seen that tumours were induced in more than one type of
tissue by each of the carcinogens, thus giving a wider scope than other methods.
In some cases adenomas occurred in the embryo lung implants with or without
accompanying squamous carcinomas (Fig. 14, 15). Where adenomas occurredtheir
presence was recorded, but not put forward as proofofcarcinogenicity on the part
ofthe hydrocarbons to which the lung implant had been exposed. This course was
decided upon because of the equivocal position of the spontaneous adenomas of
lung in mice with regard to their classification as malignant lesions. Carcinomas
were accepted as proof of carcinogenic action.
Some of the stomach implants showed an alteration in the connective tissue
ofthe forestomach (Fig. 16, 17). There was a development ofpolypoidal processes
and bridges covered by apparently normal squamous epithelium. Sometimes this
was the only abnormal finding in the graft; in others it was found to be contin-
uous with well developed squamous carcinoma. It is therefore felt that this
appearance when present can be interpreted as pre-malignant and indicative of
the need fora longer induction period than had been given up tothe timeofkilling
the particular animal.
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SUMMARY
Having compared directly by a standard method 13 polycyclic aromatic hydro-
carbons, the points of interest which emerge are as follows:
1. Blind testing of known substances gave results as reliable as those by pre-
vious methods, and correlated with what was already known of their carcinogenic
properties.
2. The induction of tumours in more than one type of tissue by each of the
known carcinogens was noted.
3. The short time of 16 weeks required to obtain the results.
4. The very small amounts of material required for each test (not more than
150 ,g.).
5. The simplicity of this single step procedure.
It is felt therefore that this method fulfils the criteria postulated at the begin-
ning of the paper and that it is a procedure which can safely be used for the bio-
assay of untested suspect substances.
This investigation was supported by a full time Research Grant from the
British Empire Cancer Campaign.
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